Editorial Commentary: Nonspecific Beneficial Effects of BCG Vaccination in High-income Countries, Should We Extend Recommendation of BCG Vaccination?
Public Health Unit, Faculty of Medicine Genética de Micobacterias, University of Zaragoza CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid.
Maria-Jose
MJ
Iglesias
Genética de Micobacterias, University of Zaragoza CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid Servicio de Microbiología, Hospital Universitario Miguel Servet, ISS Aragón, Zaragoza, Spain.
Carlos
C
Martin
D001500:BCG Vaccine / Q000008:administration & dosage*; D056738:Cross Protection; D005260:Female; D006760:Hospitalization; D006801:Humans; D064789:Immunity, Heterologous; D008297:Male; D012141:Respiratory Tract Infections / Q000517:prevention & control*; D018805:Sepsis / Q000517:prevention & control*
D001500:BCG Vaccine
Public Health; epigenomic reprograming; live vaccines; trained immunity